Bildkälla: Stockfoto

Gasporox Q3’22: Significant Beat, Positive EBITDA - Redeye

Redeye states Gasporox report was strong with beats accross the board. As a result, we will review our short-term estimates and the fair value range.

Redeye states Gasporox report was strong with beats accross the board. As a result, we will review our short-term estimates and the fair value range.
Börsvärldens nyhetsbrev
ANNONSER